Cases & Deals

Myriad acts in High Court's first consideration of genetic material patents

Client(s) Myriad Genetics, Inc.

Jones Day acted for Myriad Genetics, Inc. in a landmark Australian case before the High Court of Australia. The case represents the first time an Australian court considered the patentability of genetic material, a case in which Jones Day also acted before the U.S. Supreme Court.

D’Arcy v. Myriad Genetics Inc [2015] HCA 35